Intellectual Property India Publishes Patent Application for 'Crystalline Form Of An N-Heteroarylsulphonamide, Compositions And Methods Thereof' Filed by Pacylex Pharmaceuticals Inc.

MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517065417 A) filed by Pacylex Pharmaceuticals Inc., Calgary, Canada, on July 9, for 'crystalline form of an n-heteroarylsulphonamide, compositions and methods thereof.'

Inventor(s) include Scott, Ian Leslie; Smith, Garry Robert; Suleiman, Osama; Green, Emma Jane; and Roberge, Jacques Yves.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "A crystalline form of N-heteroarylsulphonamide 2,6-dichloro-N-(3-isobutyl-1,5- dimethyl-1H-pyrazol-4-yl)-4-(2-(piperazin-1-yl)pyridin-4-yl)benzenesulfonamide and pharmaceutical compositions thereof; and method...